Lupus nephritis in children

Lupus

Volumn 14, Issue 1, 2005, Pages 83-88

  Perfumo, F ^a   Martini, Alberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Children; Damage; Juvenile systemic lupus erythematosus; Nephritis; Outcome

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DNA ANTIBODY; LUPUS ANTICOAGULANT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHOLIPID ANTIBODY; PREDNISONE; PROTEIN; RIBONUCLEOPROTEIN ANTIBODY; STEROID;

ACNE; CLINICAL FEATURE; CLINICAL TRIAL; DIALYSIS; DISEASE ACTIVITY; DISEASE CLASSIFICATION; GRAFT SURVIVAL; GROWTH INHIBITION; HIRSUTISM; HUMAN; HYPERTENSION; INFERTILITY; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MALIGNANT NEOPLASTIC DISEASE; MOON FACE; MORBIDITY; OBESITY; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; QUALITY OF LIFE; REVIEW; RISK FACTOR; STRIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; AGE FACTORS; ANTIBODIES, ANTINUCLEAR; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; LUPUS NEPHRITIS; MALE; PROGNOSIS;

EID: 13444252480     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2065oa     Document Type: Review

References (52)

1. Klein-Gitelman M, Reiff A, Silverman ED. Systemic lupus erythematosus in childhood. Pediatr Clin N Am 2002; 28: 561-577.
2. Lehmann TJA. Systemic lupus erythematosus in childhood and adolescence. In Wallace DJ, Hahn BH eds. Dubois' Lupus Erythematosus. Philadelphia: Lippincott, 2002: 863-884.
3. Petty RE, Cassidy JT. Systemic lupus erythematosus. In Cassidy JT, Petty RE eds. Textbook of paediatric rheumatology. Philadelphia: WB Saunders, 2001: 396-449.
4. Ferraz MB, Goldenberg J, Hilario MO et al. Evaluation of the 1982 ARA lupus criteria data set in pediatric patients. Clin Exp Rheumatol 1994; 12: 83-87.
5. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995; 34: 866-872.
6. Brunner HI, Freedman M, Silverman ED. Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthritis Rheum 1999; 42: 2346-2355.
7. Font J, Cervera R, Espinosa G et al. Systemic lupus erythematosous (SLE) in childhood: analysis of clinical and immunologic findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998; 57: 456-459.
8. Ravelli A, Martini A. Antiphospholipid antibody syndrome in pediatric patients. Rheum Dis Clin N Am 1997; 23: 657-676.
9. Levy DM, Massicotte MP, Harvey E, Hebert D, Silverman ED. Thromboembolism in paediatric lupus patients. Lupus 2003; 12: 741-746.
10. Cameron JS. Lupus nephritis in childhood and adolescence. Pediatr Nephrol 1994; 8: 230-249.
11. Bogdanovic R, Nikolic V, Pasic S et al. Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr Nephrol 2004; 19: 36-44.
12. Zappitelli M, Duffy C, Bernard C et al. Clinicopathological study of the WHO classification in childhood lupus nephritis. Pediatr Nephrol 2004; 19: 503-510.
13. Sorof JM, Perez MD, Brewer ED, Hawkins EP, Warren RW. Increasing incidence of childhood class V lupus nephritis. J Rheumatol 1998; 25: 1413-1418.
14. Appel GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D. Long-term follow-up of patients with lupus nephritis: a study based on the classification of the World Health Organization. Am J Med 1987; 83: 877-885.
15. Schwartz MM, Lan SP, Bernstein J, Hill GS, Holley K, Lewis EJ. The Lupus Nephritis Collaborative Study Group. Role of pathology indices in the management of severe lupus glomerulonephritis. Kidney Int 1992; 42: 743-748.
16. Sumboonnanonda A, Suntornpoch V, Parichatikanond P, Vongjirad A, Laohapand T. Renal pathology and long-term outcome in childhood SLE. J Med Assoc Thai 1998; 81: 830-834.
17. Rush PJ, Baumal R, Shore A, Balfe JW, Schreiber M. Correlation of renal histology with outcome in children with lupus nephritis. Kidney Int 1986; 29: 1066-1071.
18. McCurdy DK, Lehman TJA, Bernstein B et al. Lupus nephritis: prognostic factors in children. Pediatrics 1992; 89: 240-246.
19. Niaudet P. Treatment of lupus nephritis in children. Pediatr Nephrol 2000; 1: 158-166.
20. Ruperto N, Martini A. International research networks in pediatric rheumatology: the PRINTO perspective. Curr Opin Rheumatol 2004; 16: 566-570.
21. White PH. Transition: a future promise for children and adolescents with special health care needs and disabilities. Rheum Dis Clin North Am 2002; 28: 687-703.
22. De Benedetti F, Maghnie M, Martini A. Growth and skeletal maturation. In Isenberg DA, Maddison PJ, Woo P, Glass D, Breedveld FC eds. Oxford Textbook of Rheumatology. Oxford University Press: Oxford, 2004: 55-60.
23. Baqi N, Moazami S, Singh A, Ahmad H, Balachandra S, Tejani A. Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 1996; 7: 924-992.
24. Hagelberg S, Lee Y, Bargman J et al. Long term follow up of childhood lupus nephritis. J Rheumatol 2002; 29: 2635-2642.
25. Lehman TJ, Onel K. Intermittent intravenopus cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr 2000; 136: 243-247.
26. Barbano G, Gusmano R, Damasio B et al. Childhood-onset lupus nephritis: a single-center experience of pulse intravenous cyclophosphamide therapy. J Nephrol 2002; 15: 123-129.
27. Boumpas DT, Austin HA 3rd, Vaughan EM, Yarboro CH, Klippel JH, Balow JE. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 1993; 119: 366-369.
28. Huong du L, Amoura Z, Duhaut P et al. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol 2002; 29: 2571-2576.
29. Latta K, von Schnakenburg C, Ehrich JH. A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 2001; 16: 271-282.
30. Fu LW, Yang LY, Chen WP, Lin CY. Clinical efficacy of cyclosporin A Neoral in the treatment of paediatric lupus nephritis with heavy proteinuria. Br J Rheumatol 1998; 37: 217-221.
31. Ravelli A, Ballardini G, Viola S, Villa I, Ruperto N, Martini A. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus. J Rheumatol 1998; 25: 572-575.
32. Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. J Rheumatol 2001; 28: 2103-2108.
33. Lehman TJ, Edelheit BS, Onel KB. Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis. Ann Rheum Dis 2004; 63: 321-323.
34. Wulffraat NM, Sanders EA, Kamphuis SS et al. Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus. Arthritis Rheum 2001; 44: 728-731.
35. Brunner HI, Feldman BM, Bombardier C, Silverman ED. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1999; 42: 1354-1360.
36. Brunner HI, Silverman ED, Bombardier C, Feldman BM. European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus. Arthritis Rheum 2003; 49: 335-341.
37. Ruperto N, Ravelli A, Murray KJ et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology 2003; 42: 1452-1459.
38. Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002; 46: 436-444.
39. Ravelli A, Duarte-Salazar C, Buratti S et al. Assessment of damage in juvenile-onset systemic lupus erythematosus. A multicenter cohort study. Arthritis Rheum 2003; 49: 501-507.
40. Ruperto N, Martini A. Quality of life in juvenile idiopathic arthritis patients compared to healthy children. Clin Exp Rheumatol 2001; 19(suppl 23): S1-S172.
41. Ruperto N, Buratti S, Duarte-Salazar C et al. Health related quality of life in juvenile-onset systemic lupus erythematosus and its relationship with disease activity and damage. Arthritis Rheum 2004; 51: 458-464.
42. Falaschi F, Ravelli A, Martignoni A et al. Nephrotic-range proteinuria is the major risk factor for early atherosclerosis in juvenile-onset sytemic lupus erythematosus. Arthritis Rheum 2000; 43: 1405-1409.
43. Yang LY, Chen WP, Lin CY. Lupus nephritis in children - a review of 167 patients. Pediatrics 1994; 94: 335-340.
44. Emre S, Bilge I, Sirin A, Kilicaslan I, Nayir A. Lupus nephritis in children: prognostic significance of clinicopathological findings. Nephron 2001; 87: 118-126.
45. Lehman TJA, McCurdy DK, Bernstein BH, King KK, Hanson V. Systemic lupus erythematosus in the first decade of life. Pediatrics 1989; 83: 235-239.
46. Fox L, Zager P, Tung AH, Smith S. Lupus nephritis in a pediatric renal ttransplant recipient. Pediatr Nephrol 1992; 6: 467-469.
47. Ward LA, Jelveh Z, Feinfeld DA. Recurrent membranous lupus nephritis after renal transplantation: a case report and review of the literature. Am J Kidney Dis 1994; 23: 326-329.
48. Bartosh SM, Fine RN, Sullivan EK. Outcome after transplantation of young patients with systemic lupus erythematosus: a report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 2001; 72: 973-978.
49. Azevedo L, Romao J, Malheiros D, Saldanha L, Ianhez L, Sabbaga E. Renal transplantation in systemic lupus erythematosus. A case control study of 45 patients. Nephrol Dial Transplant 1998; 13: 2894-2898.
50. Stone J. End stage renal disease in lupus: disease activity, dialysis and the outcome of transplantation. Nephrol Dial Transplant 1998; 13: 2894-2898.
51. Tsang WK, Tong KL, Tang HL, Chu KH, Chan HW. Thirteen-year results of renal transplantation in patients with systemic lupus erythematosus. Transplant Proc 2000; 32: 1824-1825.
52. Gipson DS, Ferris ME, Dooley MA, Huang K, Hogan SL. Renal transplantation in children with lupus nephritis. Am J Kidney Dis 2003; 41: 455-463.